Evidence map›Paper›PMID 19724293›Full record

ReviewEuropean journal of clinical nutrition2009

Vitamin D and calcium insufficiency-related chronic diseases: molecular and cellular pathophysiology.

M Peterlik, H S Cross

Registry-linked trialAbstract readReview
PubMed Publisher
In one paragraph

Review in European journal of clinical nutrition, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01210521 (Use of Vitamin D3 for the Treatment of Steroid Resistant Asthmatic Patients), which is not on this map. Cited by 43 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed, 3 pooled it
5.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01210521 phase2withdrawnnot on this mapstarted 2010, after this paper: background citation

Use of Vitamin D3 for the Treatment of Steroid Resistant Asthmatic Patients

TypeinterventionalSponsorFlorida Atlantic UniversityRan2010 to 2016Enrolled0ConditionsAsthmaArmsVitamin D
3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 3 syntheses or guidelines pooled it, 114 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Review
  7. Article
  8. Emerging perspectives: unraveling the anticancer potential of vitamin DNaunyn-Schmiedeberg's archives of pharmacology · 2024
    Review
  9. Review
  10. Article
  11. Observational
  12. Editorial: The role of minerals and trace elements in chronic diseases.Frontiers in cell and developmental biology · 2023
    Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Nutrition and Inflammatory Biomarkers in Chronic Pancreatitis Patients.Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition · 2019
    Article
  19. Observational
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

M PeterlikDepartment of Pathophysiology, University of Medicine Vienna, Vienna, Austria. meinrad.peterlik@meduniwien.ac.at
H S Cross
University of Vienna · AT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A compromised vitamin D status, characterized by low 25-hydroxyvitamin D (25-(OH)D) serum levels, and a nutritional calcium deficit are widely encountered in European and North American countries, independent of age or gender. Both conditions are linked to the pathogenesis of many degenerative, malignant, inflammatory and metabolic diseases. Studies on tissue-specific expression and activity of vitamin D metabolizing enzymes, 25-(OH)D-1 alpha-hydroxylase and 25-(OH)D-24-hydroxylase, and of the extracellular calcium-sensing receptor (CaR) have led to the understanding of how, in non-renal tissues and cellular systems, locally produced 1,25-dihydroxyvitamin D(3) (1,25-(OH)(2)D(3)) and extracellular Ca(2+) act jointly as key regulators of cellular proliferation, differentiation and function. Impairment of cooperative signalling from the 1,25-(OH)(2)D(3)-activated vitamin D receptor (VDR) and from the CaR in vitamin D and calcium insufficiency causes cellular dysfunction in many organs and biological systems, and, therefore, increases the risk of diseases, particularly of osteoporosis, colorectal and breast cancer, inflammatory bowel disease, insulin-dependent diabetes mellitus type I, metabolic syndrome, diabetes mellitus type II, hypertension and cardiovascular disease. Understanding the underlying molecular and cellular processes provides a rationale for advocating adequate intake of vitamin D and calcium in all populations, thereby preventing many chronic diseases worldwide.

Indexed as

Autoimmune DiseasesCalciumCalcium, DietaryCardiovascular DiseasesChronic DiseaseGene Expression RegulationHumansMetabolic DiseasesNeoplasmsS100 Calcium Binding Protein GVitamin DVitamin D Deficiency1,25-dihydroxyvitamin DCalciumCalcium, DietaryS100 Calcium Binding Protein GVitamin D

Identifiers

PMID19724293
OpenAlexW2063580735

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.